Details for Patent: 9,670,147

Which drugs does patent 9,670,147 protect, and when does it expire?

Patent 9,670,147 protects SKYCLARYS and is included in one NDA.

This patent has thirty-two patent family members in twenty-six countries.

Summary for Patent: 9,670,147

Title:	Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
Abstract:	This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula: wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.
Inventor(s):	Eric Anderson, Xin Jiang, Melean Visnick
Assignee:	Reata Pharmaceuticals Holdings LLC
Application Number:	US14/753,297
Patent Claim Types: see list of patent claims	Compound;

Drugs Protected by US Patent 9,670,147

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Biogen Us	SKYCLARYS	omaveloxolone	CAPSULE;ORAL	216718-001	Feb 28, 2023		RX	Yes	Yes				Y

International Family Members for US Patent 9,670,147

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2009237579
Brazil	PI0911457
Canada	2721838